QIAGEN N.V.
NASDAQ:QGEN
$15.15
-$0.43
(-2.76%)
Quote as of 4:00 PM EST on 02/10/12
Extended Hours:
$15.15
$0.00
(0.00%)
Quote as of 4:50 PM EST on 02/10/12 (NASDAQ)
|
$15.15
-$0.43
(-2.76%)
|
|
| Today's Open | $15.42 |
|---|---|
| Previous Close | $15.58 |
| Daily Range | $15.09 - $15.42 |
| 52-Week Range | $12.47 - $22.20 |
| Market Cap | $3.55B |
| P/E Ratio | 15.90 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,649,530 |
| Average Daily Volume | 1,311,520 |
| Current FY EPS | $0.97 |
QGEN Information
| Description |
|---|
| The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions. |
| Sector |
| Healthcare |
| Industry |
| Life Sciences Tools and Services |
News & Commentary
Qiagen Beats on EPS but GAAP Results Lag
Myriad Beats, Raises Guidance - Analyst Blog
Qiagen Posts a Solid 4Q - Analyst Blog
Hologic Tops Estimates - Analyst Blog
Why Qiagen's Earnings Are Outstanding
Cepheid Tops Estimates - Analyst Blog
Qiagen Enhances Presence in Japan - Analyst Blog
Why Qiagen May Be About to Take Off
Qiagen Expands QIAensemble Portfolio - Analyst Blog
FDA Nod for Hologic's Cervista HTA - Analyst Blog
